NEUROASPIS® plp10 was presented at the 7th International Conference on Drug Discovery and Therapy, Dubai, February 2016. The session on NEUROASPIS® plp10 was presented by Prof. Dr I. Patrikios. 7th International Conference on Drug Discovery and Therapy, Dubai 2016 (http://www.icddt.com/abstracts.php) Ioannis Patrikios, George Loukaides, Marios Pantzaris; Neuroactive structured lipids, the omega-3/omega-6 PUFA, MUFA and anti ROS and […]

Research publication on BMJ Open (2013) – „A novel oral nutraceutical formula of omega-3 and omega-6 fatty acids with vitamins (PLP10) in relapsing remitting multiple sclerosis: a randomised, double-blind, placebo-controlled proof-of-concept clinical trial“ BMJ Open 2013 – Research Article

APOE ε4 and the associations of seafood and long-chain omega-3 fatty acids with cognitive decline .http://www.neurology.org/content/86/22/2063

3rd Panhellenic Congress of the Hellenic Academy of NeuroImmunology on Multiple Sclerosis, Athens, 2015 (http://www.praxicon.gr/down/final3ellana15.pdf) S. Patrikios, G.N. Loucaides, M. Pantzaris Neuroactive structured lipids, the omega-3/omega-6 PUFA, MUFA and anti ROS and RNS vitamins in the treatment of neurodegenerative diseases and especially multiple sclerosis: the intervention PLP10.

The 3rd International Polythematic Scientific Bio-Medical Congress titled “Bio-Medical Scientific Cyprus” took place on Saturday, November 14th 2015, at the European University Cultural Center. Conference details Keynote Speaker: Professor Dr Ada Yonath, (Nobelist); Weizmann Institute of Science, Israel – Nobel, chemistry, 2009; structure of ribosomes Founder and General Congress Coordinator: Professor Dr Ioannis Patrikios Sponsor: […]

NEUROASPIS® plp10 was presented at ECTRIMS 2015 (http://onlinelibrary.ectrims-congress.eu/ectrims/2015/31st/115778/undefined) S. Patrikios, G.N. Loucaides, M. Pantzaris, M.A. Crawford, K. Ghebremeskel; Omega-3, Omega-6 PUFA and gamma-Tocopherol in multiple sclerosis: PLP10 intervention efficacy and red blood cells’ membrane lipids composition

Ioannis S. Patrikios, George N. Loukaides, Marios C. Pantzaris; Specific Omega3, Omega-6 Polyunsaturated Fatty Acids and γ-Tocopherol in the Therapy of Relapsing Multiple Sclerosis: the Paradigm of the PLP10 Intervention Efficacy and Correlation to the Molecular Alteration of the Red blood Cells’ Membranes; Neuroimmunology, Thessaloniki, 2014 https://www.researchgate.net/publication/266079759_Specific_Omega-3_Omega-6_Polyunsaturated_Fatty_Acids_and_g-Tocopherol_in_the_Therapy_of_Relapsing_Multiple_Sclerosis_the_Paradigm_of_the_PLP10_Intervention_Efficacy_and_Correlation_to_the_Molecular_Al

Ioannis S. Patrikios, George .N. Loukaides, Evangelia E. Ntzani, Marios C. Pantzaris. Systems Medicine, Applying Systems Biology Approaches for Manipulation of Altered Biomechanisms towards Multiple Sclerosis Treatment by the Use of Specific Structured molecules and Antioxidant Vitamins: the PLP10 intervention Paradigm. Trends in Drug Research 05/2014; 32:87-102. DOI:ISBN 978-9963-9615-3-5 http://www.quintessence.com.cy/?wp=trends-2014-home, http://www.quintessence.com.cy/?wp=trends-2014-invited-speakers

Ioannis S. Patrikios, George N. Loukaides, Evangelia E. Ntzani & Marios C. Pantzaris. Systems Medicine, Applying Systems Biology Approaches for Multiple Sclerosis Treatment by the Use of Specific Structured Μolecules and Antioxidant Vitamins: the PLP10 Novel Ιntervention Paradigm; 6th International Conference on Drug Discovery and Therapy, Dubai 2014. http://www.icddt.com/files/6th-Abstract%20Book.pdf

Ioannis S. Patrikios, George N. Loukaides, Evangelia E. Ntzani & Marios C. Pantzaris. Systems Medicine, a Novel Approach to Chronic Diseases: the example of PLP10 Multiple Sclerosis intervention treatment, a phase II clinical trial. Biomedical Scientific Cyprus, 2013. https://www.google.com.cy/#q=the+example+of+PLP+10+Multiple+Sclerosis+intervention+treatment,+a+phase+II+clinical+trial.+Biomedical+Scientific+Cyprus,+2013